nodes	percent_of_prediction	percent_of_DWPC	metapath
Galantamine—ACHE—breast cancer	0.204	0.457	CbGaD
Galantamine—BCHE—breast cancer	0.12	0.269	CbGaD
Galantamine—CYP2D6—breast cancer	0.0658	0.148	CbGaD
Galantamine—CYP3A4—breast cancer	0.0564	0.127	CbGaD
Galantamine—ACHE—Irinotecan—breast cancer	0.0395	0.162	CbGbCtD
Galantamine—BCHE—Irinotecan—breast cancer	0.0238	0.0975	CbGbCtD
Galantamine—CYP3A4—Exemestane—breast cancer	0.0186	0.0763	CbGbCtD
Galantamine—CYP2D6—Idarubicin—breast cancer	0.0168	0.0689	CbGbCtD
Galantamine—CYP3A4—Letrozole—breast cancer	0.0158	0.0649	CbGbCtD
Galantamine—CYP3A4—Anastrozole—breast cancer	0.0141	0.0578	CbGbCtD
Galantamine—CYP3A4—Toremifene—breast cancer	0.0129	0.0529	CbGbCtD
Galantamine—CYP3A4—Fulvestrant—breast cancer	0.012	0.0492	CbGbCtD
Galantamine—CYP3A4—Thiotepa—breast cancer	0.0107	0.0438	CbGbCtD
Galantamine—CYP3A4—Ixabepilone—breast cancer	0.00977	0.0401	CbGbCtD
Galantamine—CYP3A4—Lapatinib—breast cancer	0.00941	0.0386	CbGbCtD
Galantamine—CHRFAM7A—corpus luteum—breast cancer	0.00908	0.158	CbGeAlD
Galantamine—CYP2D6—Vinorelbine—breast cancer	0.00821	0.0336	CbGbCtD
Galantamine—CYP2D6—Tamoxifen—breast cancer	0.00741	0.0304	CbGbCtD
Galantamine—CHRNA7—corpus luteum—breast cancer	0.00733	0.127	CbGeAlD
Galantamine—CYP3A4—Raloxifene—breast cancer	0.00713	0.0292	CbGbCtD
Galantamine—CYP3A4—Vinorelbine—breast cancer	0.00522	0.0214	CbGbCtD
Galantamine—CYP2D6—Vinblastine—breast cancer	0.00506	0.0207	CbGbCtD
Galantamine—CYP3A4—Tamoxifen—breast cancer	0.00471	0.0193	CbGbCtD
Galantamine—CYP3A4—Mitoxantrone—breast cancer	0.00459	0.0188	CbGbCtD
Galantamine—CHRNA9—embryo—breast cancer	0.00385	0.067	CbGeAlD
Galantamine—CYP3A4—Paclitaxel—breast cancer	0.00367	0.015	CbGbCtD
Galantamine—CYP3A4—Irinotecan—breast cancer	0.00362	0.0148	CbGbCtD
Galantamine—CYP3A4—Vinblastine—breast cancer	0.00322	0.0132	CbGbCtD
Galantamine—CYP2D6—Doxorubicin—breast cancer	0.00311	0.0127	CbGbCtD
Galantamine—CHRNE—pituitary gland—breast cancer	0.00266	0.0463	CbGeAlD
Galantamine—CYP3A4—Docetaxel—breast cancer	0.00265	0.0109	CbGbCtD
Galantamine—CHRNG—nipple—breast cancer	0.00243	0.0423	CbGeAlD
Galantamine—CYP3A4—Doxorubicin—breast cancer	0.00198	0.0081	CbGbCtD
Galantamine—CHRNA6—skin of body—breast cancer	0.00165	0.0288	CbGeAlD
Galantamine—CHRNA2—mammary gland—breast cancer	0.00162	0.0281	CbGeAlD
Galantamine—CHRNB2—nipple—breast cancer	0.00148	0.0258	CbGeAlD
Galantamine—CHRNG—adipose tissue—breast cancer	0.00132	0.023	CbGeAlD
Galantamine—CHRNG—bone marrow—breast cancer	0.00115	0.02	CbGeAlD
Galantamine—CHRNB4—adrenal gland—breast cancer	0.00114	0.0199	CbGeAlD
Galantamine—CHRNA5—lymph node—breast cancer	0.000997	0.0173	CbGeAlD
Galantamine—CHRNA3—skin of body—breast cancer	0.000921	0.016	CbGeAlD
Galantamine—CHRNB2—endometrium—breast cancer	0.000895	0.0156	CbGeAlD
Galantamine—CHRNB2—uterus—breast cancer	0.000825	0.0143	CbGeAlD
Galantamine—CHRNB2—pituitary gland—breast cancer	0.00081	0.0141	CbGeAlD
Galantamine—CHRNB2—adipose tissue—breast cancer	0.000807	0.014	CbGeAlD
Galantamine—CHRNB2—adrenal gland—breast cancer	0.000724	0.0126	CbGeAlD
Galantamine—CHRNA3—adrenal gland—breast cancer	0.000702	0.0122	CbGeAlD
Galantamine—CHRNB2—bone marrow—breast cancer	0.0007	0.0122	CbGeAlD
Galantamine—CHRNA1—endocrine gland—breast cancer	0.000682	0.0119	CbGeAlD
Galantamine—CHRNB1—adipose tissue—breast cancer	0.000677	0.0118	CbGeAlD
Galantamine—CHRNB2—female gonad—breast cancer	0.000675	0.0117	CbGeAlD
Galantamine—CHRNA3—endocrine gland—breast cancer	0.000609	0.0106	CbGeAlD
Galantamine—CHRNB1—adrenal gland—breast cancer	0.000607	0.0106	CbGeAlD
Galantamine—CHRNA10—lymph node—breast cancer	0.000604	0.0105	CbGeAlD
Galantamine—CHRNA7—skin of body—breast cancer	0.000602	0.0105	CbGeAlD
Galantamine—CHRFAM7A—female reproductive system—breast cancer	0.000582	0.0101	CbGeAlD
Galantamine—CHRNB1—female gonad—breast cancer	0.000566	0.00985	CbGeAlD
Galantamine—CHRNA2—endocrine gland—breast cancer	0.000566	0.00984	CbGeAlD
Galantamine—BCHE—nipple—breast cancer	0.00053	0.00922	CbGeAlD
Galantamine—CHRFAM7A—female gonad—breast cancer	0.000529	0.00921	CbGeAlD
Galantamine—ACHE—adrenal gland—breast cancer	0.000527	0.00916	CbGeAlD
Galantamine—CHRNA7—uterus—breast cancer	0.000523	0.00909	CbGeAlD
Galantamine—CHRFAM7A—endocrine gland—breast cancer	0.000492	0.00856	CbGeAlD
Galantamine—CHRNA7—female reproductive system—breast cancer	0.00047	0.00817	CbGeAlD
Galantamine—CHRNA7—adrenal gland—breast cancer	0.000459	0.00797	CbGeAlD
Galantamine—CHRNA4—adrenal gland—breast cancer	0.000452	0.00787	CbGeAlD
Galantamine—CHRNB2—lymph node—breast cancer	0.000434	0.00755	CbGeAlD
Galantamine—CHRNA7—female gonad—breast cancer	0.000428	0.00743	CbGeAlD
Galantamine—CHRNA3—lymph node—breast cancer	0.000421	0.00732	CbGeAlD
Galantamine—CHRNA7—endocrine gland—breast cancer	0.000398	0.00691	CbGeAlD
Galantamine—CHRNA4—endocrine gland—breast cancer	0.000392	0.00682	CbGeAlD
Galantamine—CHRNB1—lymph node—breast cancer	0.000364	0.00633	CbGeAlD
Galantamine—BCHE—skin of body—breast cancer	0.00034	0.0059	CbGeAlD
Galantamine—BCHE—endometrium—breast cancer	0.00032	0.00557	CbGeAlD
Galantamine—ACHE—lymph node—breast cancer	0.000316	0.00549	CbGeAlD
Galantamine—BCHE—uterus—breast cancer	0.000295	0.00513	CbGeAlD
Galantamine—BCHE—pituitary gland—breast cancer	0.00029	0.00504	CbGeAlD
Galantamine—BCHE—adipose tissue—breast cancer	0.000288	0.00502	CbGeAlD
Galantamine—Dihydrocodeine—CYP2D6—breast cancer	0.000288	0.114	CrCbGaD
Galantamine—BCHE—female reproductive system—breast cancer	0.000265	0.00461	CbGeAlD
Galantamine—BCHE—adrenal gland—breast cancer	0.000259	0.0045	CbGeAlD
Galantamine—BCHE—bone marrow—breast cancer	0.00025	0.00435	CbGeAlD
Galantamine—Dihydrocodeine—CYP3A4—breast cancer	0.000247	0.0979	CrCbGaD
Galantamine—Ethylmorphine—CYP2D6—breast cancer	0.000241	0.0956	CrCbGaD
Galantamine—BCHE—endocrine gland—breast cancer	0.000224	0.0039	CbGeAlD
Galantamine—Hydrocodone—CYP2D6—breast cancer	0.000221	0.0874	CrCbGaD
Galantamine—Ethylmorphine—CYP3A4—breast cancer	0.000207	0.082	CrCbGaD
Galantamine—Oxycodone—CYP2D6—breast cancer	0.000201	0.0798	CrCbGaD
Galantamine—Codeine—CYP2D6—breast cancer	0.000192	0.0761	CrCbGaD
Galantamine—Hydrocodone—CYP3A4—breast cancer	0.000189	0.075	CrCbGaD
Galantamine—CYP3A4—female reproductive system—breast cancer	0.000179	0.0031	CbGeAlD
Galantamine—CYP2D6—female reproductive system—breast cancer	0.000176	0.00305	CbGeAlD
Galantamine—Oxycodone—CYP3A4—breast cancer	0.000173	0.0684	CrCbGaD
Galantamine—Codeine—CYP3A4—breast cancer	0.000165	0.0653	CrCbGaD
Galantamine—CYP2D6—female gonad—breast cancer	0.00016	0.00278	CbGeAlD
Galantamine—Morphine—CYP2D6—breast cancer	0.000155	0.0616	CrCbGaD
Galantamine—BCHE—lymph node—breast cancer	0.000155	0.0027	CbGeAlD
Galantamine—CYP3A4—endocrine gland—breast cancer	0.000151	0.00263	CbGeAlD
Galantamine—CYP2D6—endocrine gland—breast cancer	0.000149	0.00259	CbGeAlD
Galantamine—Morphine—CYP3A4—breast cancer	0.000133	0.0528	CrCbGaD
Galantamine—Morphine—ABCB1—breast cancer	0.000111	0.044	CrCbGaD
Galantamine—Headache—Irinotecan—breast cancer	3.88e-05	0.000209	CcSEcCtD
Galantamine—Headache—Mitoxantrone—breast cancer	3.88e-05	0.000209	CcSEcCtD
Galantamine—Hypotension—Capecitabine—breast cancer	3.87e-05	0.000209	CcSEcCtD
Galantamine—Insomnia—Docetaxel—breast cancer	3.87e-05	0.000209	CcSEcCtD
Galantamine—Paraesthesia—Docetaxel—breast cancer	3.84e-05	0.000208	CcSEcCtD
Galantamine—Vomiting—Gemcitabine—breast cancer	3.84e-05	0.000207	CcSEcCtD
Galantamine—Bradycardia—Doxorubicin—breast cancer	3.83e-05	0.000207	CcSEcCtD
Galantamine—Somnolence—Docetaxel—breast cancer	3.81e-05	0.000205	CcSEcCtD
Galantamine—Mental disorder—Methotrexate—breast cancer	3.8e-05	0.000205	CcSEcCtD
Galantamine—Rash—Gemcitabine—breast cancer	3.8e-05	0.000205	CcSEcCtD
Galantamine—Dermatitis—Gemcitabine—breast cancer	3.8e-05	0.000205	CcSEcCtD
Galantamine—Eye disorder—Epirubicin—breast cancer	3.8e-05	0.000205	CcSEcCtD
Galantamine—Tinnitus—Epirubicin—breast cancer	3.79e-05	0.000205	CcSEcCtD
Galantamine—Malnutrition—Methotrexate—breast cancer	3.78e-05	0.000204	CcSEcCtD
Galantamine—Haemoglobin—Doxorubicin—breast cancer	3.78e-05	0.000204	CcSEcCtD
Galantamine—Headache—Gemcitabine—breast cancer	3.78e-05	0.000204	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Capecitabine—breast cancer	3.78e-05	0.000204	CcSEcCtD
Galantamine—Cardiac disorder—Epirubicin—breast cancer	3.77e-05	0.000204	CcSEcCtD
Galantamine—Flushing—Epirubicin—breast cancer	3.77e-05	0.000204	CcSEcCtD
Galantamine—Vomiting—Fluorouracil—breast cancer	3.77e-05	0.000204	CcSEcCtD
Galantamine—Rhinitis—Doxorubicin—breast cancer	3.77e-05	0.000204	CcSEcCtD
Galantamine—Dyspepsia—Docetaxel—breast cancer	3.77e-05	0.000203	CcSEcCtD
Galantamine—Haemorrhage—Doxorubicin—breast cancer	3.76e-05	0.000203	CcSEcCtD
Galantamine—Hepatitis—Doxorubicin—breast cancer	3.76e-05	0.000203	CcSEcCtD
Galantamine—Insomnia—Capecitabine—breast cancer	3.75e-05	0.000202	CcSEcCtD
Galantamine—Rash—Fluorouracil—breast cancer	3.74e-05	0.000202	CcSEcCtD
Galantamine—Dermatitis—Fluorouracil—breast cancer	3.74e-05	0.000202	CcSEcCtD
Galantamine—Paraesthesia—Capecitabine—breast cancer	3.72e-05	0.000201	CcSEcCtD
Galantamine—Decreased appetite—Docetaxel—breast cancer	3.72e-05	0.000201	CcSEcCtD
Galantamine—Hypersensitivity—Paclitaxel—breast cancer	3.72e-05	0.000201	CcSEcCtD
Galantamine—Headache—Fluorouracil—breast cancer	3.72e-05	0.000201	CcSEcCtD
Galantamine—Urinary tract disorder—Doxorubicin—breast cancer	3.71e-05	0.000201	CcSEcCtD
Galantamine—Oedema peripheral—Doxorubicin—breast cancer	3.7e-05	0.0002	CcSEcCtD
Galantamine—Dysgeusia—Methotrexate—breast cancer	3.7e-05	0.0002	CcSEcCtD
Galantamine—Gastrointestinal disorder—Docetaxel—breast cancer	3.7e-05	0.0002	CcSEcCtD
Galantamine—Connective tissue disorder—Doxorubicin—breast cancer	3.7e-05	0.0002	CcSEcCtD
Galantamine—Fatigue—Docetaxel—breast cancer	3.69e-05	0.000199	CcSEcCtD
Galantamine—Angiopathy—Epirubicin—breast cancer	3.69e-05	0.000199	CcSEcCtD
Galantamine—Urethral disorder—Doxorubicin—breast cancer	3.69e-05	0.000199	CcSEcCtD
Galantamine—Nausea—Mitoxantrone—breast cancer	3.68e-05	0.000199	CcSEcCtD
Galantamine—Nausea—Irinotecan—breast cancer	3.68e-05	0.000199	CcSEcCtD
Galantamine—Immune system disorder—Epirubicin—breast cancer	3.67e-05	0.000198	CcSEcCtD
Galantamine—Constipation—Docetaxel—breast cancer	3.66e-05	0.000198	CcSEcCtD
Galantamine—Back pain—Methotrexate—breast cancer	3.66e-05	0.000197	CcSEcCtD
Galantamine—Dyspepsia—Capecitabine—breast cancer	3.65e-05	0.000197	CcSEcCtD
Galantamine—Arrhythmia—Epirubicin—breast cancer	3.63e-05	0.000196	CcSEcCtD
Galantamine—Visual impairment—Doxorubicin—breast cancer	3.62e-05	0.000196	CcSEcCtD
Galantamine—Asthenia—Paclitaxel—breast cancer	3.62e-05	0.000196	CcSEcCtD
Galantamine—Decreased appetite—Capecitabine—breast cancer	3.6e-05	0.000195	CcSEcCtD
Galantamine—Nausea—Gemcitabine—breast cancer	3.58e-05	0.000193	CcSEcCtD
Galantamine—Gastrointestinal disorder—Capecitabine—breast cancer	3.58e-05	0.000193	CcSEcCtD
Galantamine—Fatigue—Capecitabine—breast cancer	3.57e-05	0.000193	CcSEcCtD
Galantamine—Vision blurred—Methotrexate—breast cancer	3.56e-05	0.000192	CcSEcCtD
Galantamine—Mental disorder—Epirubicin—breast cancer	3.56e-05	0.000192	CcSEcCtD
Galantamine—Constipation—Capecitabine—breast cancer	3.54e-05	0.000191	CcSEcCtD
Galantamine—Malnutrition—Epirubicin—breast cancer	3.54e-05	0.000191	CcSEcCtD
Galantamine—Feeling abnormal—Docetaxel—breast cancer	3.53e-05	0.00019	CcSEcCtD
Galantamine—Nausea—Fluorouracil—breast cancer	3.52e-05	0.00019	CcSEcCtD
Galantamine—Eye disorder—Doxorubicin—breast cancer	3.51e-05	0.00019	CcSEcCtD
Galantamine—Ill-defined disorder—Methotrexate—breast cancer	3.51e-05	0.000189	CcSEcCtD
Galantamine—Tinnitus—Doxorubicin—breast cancer	3.51e-05	0.000189	CcSEcCtD
Galantamine—Gastrointestinal pain—Docetaxel—breast cancer	3.5e-05	0.000189	CcSEcCtD
Galantamine—Anaemia—Methotrexate—breast cancer	3.49e-05	0.000189	CcSEcCtD
Galantamine—Flushing—Doxorubicin—breast cancer	3.49e-05	0.000188	CcSEcCtD
Galantamine—Cardiac disorder—Doxorubicin—breast cancer	3.49e-05	0.000188	CcSEcCtD
Galantamine—Flatulence—Epirubicin—breast cancer	3.49e-05	0.000188	CcSEcCtD
Galantamine—Tension—Epirubicin—breast cancer	3.47e-05	0.000187	CcSEcCtD
Galantamine—Dysgeusia—Epirubicin—breast cancer	3.46e-05	0.000187	CcSEcCtD
Galantamine—Diarrhoea—Paclitaxel—breast cancer	3.46e-05	0.000187	CcSEcCtD
Galantamine—Nervousness—Epirubicin—breast cancer	3.44e-05	0.000186	CcSEcCtD
Galantamine—Back pain—Epirubicin—breast cancer	3.42e-05	0.000185	CcSEcCtD
Galantamine—Feeling abnormal—Capecitabine—breast cancer	3.42e-05	0.000184	CcSEcCtD
Galantamine—Angiopathy—Doxorubicin—breast cancer	3.41e-05	0.000184	CcSEcCtD
Galantamine—Malaise—Methotrexate—breast cancer	3.41e-05	0.000184	CcSEcCtD
Galantamine—Muscle spasms—Epirubicin—breast cancer	3.4e-05	0.000184	CcSEcCtD
Galantamine—Immune system disorder—Doxorubicin—breast cancer	3.4e-05	0.000183	CcSEcCtD
Galantamine—Vertigo—Methotrexate—breast cancer	3.4e-05	0.000183	CcSEcCtD
Galantamine—Gastrointestinal pain—Capecitabine—breast cancer	3.39e-05	0.000183	CcSEcCtD
Galantamine—Abdominal pain—Docetaxel—breast cancer	3.38e-05	0.000183	CcSEcCtD
Galantamine—Body temperature increased—Docetaxel—breast cancer	3.38e-05	0.000183	CcSEcCtD
Galantamine—Arrhythmia—Doxorubicin—breast cancer	3.36e-05	0.000181	CcSEcCtD
Galantamine—Dizziness—Paclitaxel—breast cancer	3.34e-05	0.00018	CcSEcCtD
Galantamine—Vision blurred—Epirubicin—breast cancer	3.33e-05	0.00018	CcSEcCtD
Galantamine—Cough—Methotrexate—breast cancer	3.3e-05	0.000178	CcSEcCtD
Galantamine—Mental disorder—Doxorubicin—breast cancer	3.29e-05	0.000178	CcSEcCtD
Galantamine—Ill-defined disorder—Epirubicin—breast cancer	3.28e-05	0.000177	CcSEcCtD
Galantamine—Body temperature increased—Capecitabine—breast cancer	3.28e-05	0.000177	CcSEcCtD
Galantamine—Abdominal pain—Capecitabine—breast cancer	3.28e-05	0.000177	CcSEcCtD
Galantamine—Convulsion—Methotrexate—breast cancer	3.28e-05	0.000177	CcSEcCtD
Galantamine—Malnutrition—Doxorubicin—breast cancer	3.27e-05	0.000177	CcSEcCtD
Galantamine—Anaemia—Epirubicin—breast cancer	3.27e-05	0.000177	CcSEcCtD
Galantamine—Agitation—Epirubicin—breast cancer	3.25e-05	0.000176	CcSEcCtD
Galantamine—Flatulence—Doxorubicin—breast cancer	3.23e-05	0.000174	CcSEcCtD
Galantamine—Myalgia—Methotrexate—breast cancer	3.22e-05	0.000174	CcSEcCtD
Galantamine—Arthralgia—Methotrexate—breast cancer	3.22e-05	0.000174	CcSEcCtD
Galantamine—Chest pain—Methotrexate—breast cancer	3.22e-05	0.000174	CcSEcCtD
Galantamine—Tension—Doxorubicin—breast cancer	3.21e-05	0.000173	CcSEcCtD
Galantamine—Vomiting—Paclitaxel—breast cancer	3.21e-05	0.000173	CcSEcCtD
Galantamine—Dysgeusia—Doxorubicin—breast cancer	3.21e-05	0.000173	CcSEcCtD
Galantamine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	3.2e-05	0.000173	CcSEcCtD
Galantamine—Malaise—Epirubicin—breast cancer	3.19e-05	0.000172	CcSEcCtD
Galantamine—Rash—Paclitaxel—breast cancer	3.18e-05	0.000172	CcSEcCtD
Galantamine—Dermatitis—Paclitaxel—breast cancer	3.18e-05	0.000172	CcSEcCtD
Galantamine—Discomfort—Methotrexate—breast cancer	3.18e-05	0.000172	CcSEcCtD
Galantamine—Nervousness—Doxorubicin—breast cancer	3.18e-05	0.000172	CcSEcCtD
Galantamine—Vertigo—Epirubicin—breast cancer	3.18e-05	0.000172	CcSEcCtD
Galantamine—Syncope—Epirubicin—breast cancer	3.17e-05	0.000171	CcSEcCtD
Galantamine—Back pain—Doxorubicin—breast cancer	3.17e-05	0.000171	CcSEcCtD
Galantamine—Headache—Paclitaxel—breast cancer	3.16e-05	0.000171	CcSEcCtD
Galantamine—Hypersensitivity—Docetaxel—breast cancer	3.15e-05	0.00017	CcSEcCtD
Galantamine—Muscle spasms—Doxorubicin—breast cancer	3.15e-05	0.00017	CcSEcCtD
Galantamine—Palpitations—Epirubicin—breast cancer	3.13e-05	0.000169	CcSEcCtD
Galantamine—Confusional state—Methotrexate—breast cancer	3.11e-05	0.000168	CcSEcCtD
Galantamine—Loss of consciousness—Epirubicin—breast cancer	3.11e-05	0.000168	CcSEcCtD
Galantamine—Cough—Epirubicin—breast cancer	3.09e-05	0.000167	CcSEcCtD
Galantamine—Vision blurred—Doxorubicin—breast cancer	3.08e-05	0.000167	CcSEcCtD
Galantamine—Asthenia—Docetaxel—breast cancer	3.07e-05	0.000166	CcSEcCtD
Galantamine—Convulsion—Epirubicin—breast cancer	3.07e-05	0.000166	CcSEcCtD
Galantamine—Hypertension—Epirubicin—breast cancer	3.05e-05	0.000165	CcSEcCtD
Galantamine—Hypersensitivity—Capecitabine—breast cancer	3.05e-05	0.000165	CcSEcCtD
Galantamine—Ill-defined disorder—Doxorubicin—breast cancer	3.04e-05	0.000164	CcSEcCtD
Galantamine—Nervous system disorder—Methotrexate—breast cancer	3.03e-05	0.000163	CcSEcCtD
Galantamine—Anaemia—Doxorubicin—breast cancer	3.03e-05	0.000163	CcSEcCtD
Galantamine—Thrombocytopenia—Methotrexate—breast cancer	3.02e-05	0.000163	CcSEcCtD
Galantamine—Myalgia—Epirubicin—breast cancer	3.01e-05	0.000163	CcSEcCtD
Galantamine—Chest pain—Epirubicin—breast cancer	3.01e-05	0.000163	CcSEcCtD
Galantamine—Arthralgia—Epirubicin—breast cancer	3.01e-05	0.000163	CcSEcCtD
Galantamine—Agitation—Doxorubicin—breast cancer	3.01e-05	0.000162	CcSEcCtD
Galantamine—Anxiety—Epirubicin—breast cancer	3e-05	0.000162	CcSEcCtD
Galantamine—Nausea—Paclitaxel—breast cancer	3e-05	0.000162	CcSEcCtD
Galantamine—Skin disorder—Methotrexate—breast cancer	3e-05	0.000162	CcSEcCtD
Galantamine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	2.99e-05	0.000162	CcSEcCtD
Galantamine—Hyperhidrosis—Methotrexate—breast cancer	2.98e-05	0.000161	CcSEcCtD
Galantamine—Discomfort—Epirubicin—breast cancer	2.98e-05	0.000161	CcSEcCtD
Galantamine—Asthenia—Capecitabine—breast cancer	2.97e-05	0.000161	CcSEcCtD
Galantamine—Malaise—Doxorubicin—breast cancer	2.95e-05	0.000159	CcSEcCtD
Galantamine—Dry mouth—Epirubicin—breast cancer	2.95e-05	0.000159	CcSEcCtD
Galantamine—Vertigo—Doxorubicin—breast cancer	2.94e-05	0.000159	CcSEcCtD
Galantamine—Anorexia—Methotrexate—breast cancer	2.94e-05	0.000159	CcSEcCtD
Galantamine—Syncope—Doxorubicin—breast cancer	2.94e-05	0.000159	CcSEcCtD
Galantamine—Diarrhoea—Docetaxel—breast cancer	2.93e-05	0.000158	CcSEcCtD
Galantamine—Confusional state—Epirubicin—breast cancer	2.91e-05	0.000157	CcSEcCtD
Galantamine—Palpitations—Doxorubicin—breast cancer	2.89e-05	0.000156	CcSEcCtD
Galantamine—Hypotension—Methotrexate—breast cancer	2.88e-05	0.000156	CcSEcCtD
Galantamine—Loss of consciousness—Doxorubicin—breast cancer	2.88e-05	0.000155	CcSEcCtD
Galantamine—Cough—Doxorubicin—breast cancer	2.86e-05	0.000154	CcSEcCtD
Galantamine—Shock—Epirubicin—breast cancer	2.84e-05	0.000153	CcSEcCtD
Galantamine—Convulsion—Doxorubicin—breast cancer	2.84e-05	0.000153	CcSEcCtD
Galantamine—Diarrhoea—Capecitabine—breast cancer	2.84e-05	0.000153	CcSEcCtD
Galantamine—Nervous system disorder—Epirubicin—breast cancer	2.83e-05	0.000153	CcSEcCtD
Galantamine—Dizziness—Docetaxel—breast cancer	2.83e-05	0.000153	CcSEcCtD
Galantamine—Thrombocytopenia—Epirubicin—breast cancer	2.83e-05	0.000153	CcSEcCtD
Galantamine—Hypertension—Doxorubicin—breast cancer	2.83e-05	0.000153	CcSEcCtD
Galantamine—Tachycardia—Epirubicin—breast cancer	2.82e-05	0.000152	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Methotrexate—breast cancer	2.81e-05	0.000152	CcSEcCtD
Galantamine—Skin disorder—Epirubicin—breast cancer	2.8e-05	0.000151	CcSEcCtD
Galantamine—Hyperhidrosis—Epirubicin—breast cancer	2.79e-05	0.000151	CcSEcCtD
Galantamine—Insomnia—Methotrexate—breast cancer	2.79e-05	0.000151	CcSEcCtD
Galantamine—Arthralgia—Doxorubicin—breast cancer	2.79e-05	0.00015	CcSEcCtD
Galantamine—Myalgia—Doxorubicin—breast cancer	2.79e-05	0.00015	CcSEcCtD
Galantamine—Chest pain—Doxorubicin—breast cancer	2.79e-05	0.00015	CcSEcCtD
Galantamine—Anxiety—Doxorubicin—breast cancer	2.78e-05	0.00015	CcSEcCtD
Galantamine—Paraesthesia—Methotrexate—breast cancer	2.77e-05	0.00015	CcSEcCtD
Galantamine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	2.77e-05	0.000149	CcSEcCtD
Galantamine—Discomfort—Doxorubicin—breast cancer	2.75e-05	0.000149	CcSEcCtD
Galantamine—Anorexia—Epirubicin—breast cancer	2.75e-05	0.000149	CcSEcCtD
Galantamine—Somnolence—Methotrexate—breast cancer	2.74e-05	0.000148	CcSEcCtD
Galantamine—Dizziness—Capecitabine—breast cancer	2.74e-05	0.000148	CcSEcCtD
Galantamine—Dry mouth—Doxorubicin—breast cancer	2.73e-05	0.000147	CcSEcCtD
Galantamine—Vomiting—Docetaxel—breast cancer	2.72e-05	0.000147	CcSEcCtD
Galantamine—Dyspepsia—Methotrexate—breast cancer	2.72e-05	0.000147	CcSEcCtD
Galantamine—Rash—Docetaxel—breast cancer	2.7e-05	0.000146	CcSEcCtD
Galantamine—Hypotension—Epirubicin—breast cancer	2.7e-05	0.000146	CcSEcCtD
Galantamine—Dermatitis—Docetaxel—breast cancer	2.7e-05	0.000146	CcSEcCtD
Galantamine—Confusional state—Doxorubicin—breast cancer	2.69e-05	0.000145	CcSEcCtD
Galantamine—Decreased appetite—Methotrexate—breast cancer	2.68e-05	0.000145	CcSEcCtD
Galantamine—Headache—Docetaxel—breast cancer	2.68e-05	0.000145	CcSEcCtD
Galantamine—Gastrointestinal disorder—Methotrexate—breast cancer	2.66e-05	0.000144	CcSEcCtD
Galantamine—Fatigue—Methotrexate—breast cancer	2.66e-05	0.000144	CcSEcCtD
Galantamine—Vomiting—Capecitabine—breast cancer	2.64e-05	0.000142	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Epirubicin—breast cancer	2.63e-05	0.000142	CcSEcCtD
Galantamine—Shock—Doxorubicin—breast cancer	2.63e-05	0.000142	CcSEcCtD
Galantamine—Nervous system disorder—Doxorubicin—breast cancer	2.62e-05	0.000141	CcSEcCtD
Galantamine—Thrombocytopenia—Doxorubicin—breast cancer	2.62e-05	0.000141	CcSEcCtD
Galantamine—Rash—Capecitabine—breast cancer	2.61e-05	0.000141	CcSEcCtD
Galantamine—Insomnia—Epirubicin—breast cancer	2.61e-05	0.000141	CcSEcCtD
Galantamine—Dermatitis—Capecitabine—breast cancer	2.61e-05	0.000141	CcSEcCtD
Galantamine—Tachycardia—Doxorubicin—breast cancer	2.61e-05	0.000141	CcSEcCtD
Galantamine—Headache—Capecitabine—breast cancer	2.6e-05	0.00014	CcSEcCtD
Galantamine—Skin disorder—Doxorubicin—breast cancer	2.59e-05	0.00014	CcSEcCtD
Galantamine—Paraesthesia—Epirubicin—breast cancer	2.59e-05	0.00014	CcSEcCtD
Galantamine—Hyperhidrosis—Doxorubicin—breast cancer	2.58e-05	0.000139	CcSEcCtD
Galantamine—Somnolence—Epirubicin—breast cancer	2.57e-05	0.000139	CcSEcCtD
Galantamine—Anorexia—Doxorubicin—breast cancer	2.55e-05	0.000138	CcSEcCtD
Galantamine—Nausea—Docetaxel—breast cancer	2.54e-05	0.000137	CcSEcCtD
Galantamine—Feeling abnormal—Methotrexate—breast cancer	2.54e-05	0.000137	CcSEcCtD
Galantamine—Dyspepsia—Epirubicin—breast cancer	2.54e-05	0.000137	CcSEcCtD
Galantamine—Gastrointestinal pain—Methotrexate—breast cancer	2.52e-05	0.000136	CcSEcCtD
Galantamine—Decreased appetite—Epirubicin—breast cancer	2.51e-05	0.000136	CcSEcCtD
Galantamine—Hypotension—Doxorubicin—breast cancer	2.5e-05	0.000135	CcSEcCtD
Galantamine—Gastrointestinal disorder—Epirubicin—breast cancer	2.49e-05	0.000135	CcSEcCtD
Galantamine—Fatigue—Epirubicin—breast cancer	2.49e-05	0.000134	CcSEcCtD
Galantamine—Constipation—Epirubicin—breast cancer	2.47e-05	0.000133	CcSEcCtD
Galantamine—Nausea—Capecitabine—breast cancer	2.46e-05	0.000133	CcSEcCtD
Galantamine—Abdominal pain—Methotrexate—breast cancer	2.44e-05	0.000132	CcSEcCtD
Galantamine—Body temperature increased—Methotrexate—breast cancer	2.44e-05	0.000132	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Doxorubicin—breast cancer	2.43e-05	0.000131	CcSEcCtD
Galantamine—Insomnia—Doxorubicin—breast cancer	2.42e-05	0.00013	CcSEcCtD
Galantamine—Paraesthesia—Doxorubicin—breast cancer	2.4e-05	0.00013	CcSEcCtD
Galantamine—Feeling abnormal—Epirubicin—breast cancer	2.38e-05	0.000128	CcSEcCtD
Galantamine—Somnolence—Doxorubicin—breast cancer	2.37e-05	0.000128	CcSEcCtD
Galantamine—Gastrointestinal pain—Epirubicin—breast cancer	2.36e-05	0.000127	CcSEcCtD
Galantamine—Dyspepsia—Doxorubicin—breast cancer	2.35e-05	0.000127	CcSEcCtD
Galantamine—Decreased appetite—Doxorubicin—breast cancer	2.32e-05	0.000125	CcSEcCtD
Galantamine—Gastrointestinal disorder—Doxorubicin—breast cancer	2.31e-05	0.000125	CcSEcCtD
Galantamine—Fatigue—Doxorubicin—breast cancer	2.3e-05	0.000124	CcSEcCtD
Galantamine—Constipation—Doxorubicin—breast cancer	2.28e-05	0.000123	CcSEcCtD
Galantamine—Abdominal pain—Epirubicin—breast cancer	2.28e-05	0.000123	CcSEcCtD
Galantamine—Body temperature increased—Epirubicin—breast cancer	2.28e-05	0.000123	CcSEcCtD
Galantamine—Hypersensitivity—Methotrexate—breast cancer	2.27e-05	0.000123	CcSEcCtD
Galantamine—Asthenia—Methotrexate—breast cancer	2.21e-05	0.00012	CcSEcCtD
Galantamine—Feeling abnormal—Doxorubicin—breast cancer	2.2e-05	0.000119	CcSEcCtD
Galantamine—Gastrointestinal pain—Doxorubicin—breast cancer	2.18e-05	0.000118	CcSEcCtD
Galantamine—Hypersensitivity—Epirubicin—breast cancer	2.13e-05	0.000115	CcSEcCtD
Galantamine—Abdominal pain—Doxorubicin—breast cancer	2.11e-05	0.000114	CcSEcCtD
Galantamine—Body temperature increased—Doxorubicin—breast cancer	2.11e-05	0.000114	CcSEcCtD
Galantamine—Diarrhoea—Methotrexate—breast cancer	2.11e-05	0.000114	CcSEcCtD
Galantamine—Asthenia—Epirubicin—breast cancer	2.07e-05	0.000112	CcSEcCtD
Galantamine—Dizziness—Methotrexate—breast cancer	2.04e-05	0.00011	CcSEcCtD
Galantamine—Diarrhoea—Epirubicin—breast cancer	1.98e-05	0.000107	CcSEcCtD
Galantamine—Hypersensitivity—Doxorubicin—breast cancer	1.97e-05	0.000106	CcSEcCtD
Galantamine—Vomiting—Methotrexate—breast cancer	1.96e-05	0.000106	CcSEcCtD
Galantamine—Rash—Methotrexate—breast cancer	1.95e-05	0.000105	CcSEcCtD
Galantamine—Dermatitis—Methotrexate—breast cancer	1.94e-05	0.000105	CcSEcCtD
Galantamine—Headache—Methotrexate—breast cancer	1.93e-05	0.000104	CcSEcCtD
Galantamine—Asthenia—Doxorubicin—breast cancer	1.92e-05	0.000104	CcSEcCtD
Galantamine—Dizziness—Epirubicin—breast cancer	1.91e-05	0.000103	CcSEcCtD
Galantamine—Vomiting—Epirubicin—breast cancer	1.84e-05	9.91e-05	CcSEcCtD
Galantamine—Nausea—Methotrexate—breast cancer	1.83e-05	9.9e-05	CcSEcCtD
Galantamine—Diarrhoea—Doxorubicin—breast cancer	1.83e-05	9.87e-05	CcSEcCtD
Galantamine—Rash—Epirubicin—breast cancer	1.82e-05	9.83e-05	CcSEcCtD
Galantamine—Dermatitis—Epirubicin—breast cancer	1.82e-05	9.82e-05	CcSEcCtD
Galantamine—Headache—Epirubicin—breast cancer	1.81e-05	9.77e-05	CcSEcCtD
Galantamine—Dizziness—Doxorubicin—breast cancer	1.77e-05	9.54e-05	CcSEcCtD
Galantamine—Nausea—Epirubicin—breast cancer	1.72e-05	9.26e-05	CcSEcCtD
Galantamine—Vomiting—Doxorubicin—breast cancer	1.7e-05	9.17e-05	CcSEcCtD
Galantamine—Rash—Doxorubicin—breast cancer	1.68e-05	9.1e-05	CcSEcCtD
Galantamine—Dermatitis—Doxorubicin—breast cancer	1.68e-05	9.09e-05	CcSEcCtD
Galantamine—Headache—Doxorubicin—breast cancer	1.67e-05	9.04e-05	CcSEcCtD
Galantamine—Nausea—Doxorubicin—breast cancer	1.59e-05	8.57e-05	CcSEcCtD
Galantamine—BCHE—Metabolism—PTGS1—breast cancer	7.27e-06	0.000112	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	7.24e-06	0.000111	CbGpPWpGaD
Galantamine—ACHE—Metabolism—NQO1—breast cancer	7.23e-06	0.000111	CbGpPWpGaD
Galantamine—ACHE—Metabolism—SLC2A1—breast cancer	7.23e-06	0.000111	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—ALB—breast cancer	7.15e-06	0.00011	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—APRT—breast cancer	7.14e-06	0.00011	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CYP2D6—breast cancer	7.13e-06	0.00011	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	7.08e-06	0.000109	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—MMP2—breast cancer	7.07e-06	0.000109	CbGpPWpGaD
Galantamine—ACHE—Neuronal System—HRAS—breast cancer	7.06e-06	0.000108	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CYP3A4—breast cancer	7.05e-06	0.000108	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	7.01e-06	0.000108	CbGpPWpGaD
Galantamine—BCHE—Metabolism—NCOA2—breast cancer	7e-06	0.000108	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CYP1B1—breast cancer	6.93e-06	0.000106	CbGpPWpGaD
Galantamine—ACHE—Metabolism—HSP90AA1—breast cancer	6.8e-06	0.000104	CbGpPWpGaD
Galantamine—BCHE—Metabolism—FASN—breast cancer	6.79e-06	0.000104	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ANGPTL4—breast cancer	6.71e-06	0.000103	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ESRRA—breast cancer	6.71e-06	0.000103	CbGpPWpGaD
Galantamine—BCHE—Metabolism—SLC5A5—breast cancer	6.68e-06	0.000103	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—SYNJ2—breast cancer	6.63e-06	0.000102	CbGpPWpGaD
Galantamine—ACHE—Metabolism—NCOA1—breast cancer	6.61e-06	0.000102	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—IGF1—breast cancer	6.52e-06	0.0001	CbGpPWpGaD
Galantamine—ACHE—Metabolism—STK11—breast cancer	6.52e-06	0.0001	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CYP19A1—breast cancer	6.52e-06	0.0001	CbGpPWpGaD
Galantamine—BCHE—Metabolism—NQO1—breast cancer	6.45e-06	9.91e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—SLC2A1—breast cancer	6.45e-06	9.91e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—HADHB—breast cancer	6.36e-06	9.78e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GPI—breast cancer	6.36e-06	9.78e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	6.31e-06	9.7e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—MMP2—breast cancer	6.31e-06	9.69e-05	CbGpPWpGaD
Galantamine—BCHE—Neuronal System—HRAS—breast cancer	6.3e-06	9.68e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CYP3A4—breast cancer	6.29e-06	9.66e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	6.26e-06	9.61e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CYP1B1—breast cancer	6.18e-06	9.5e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—NDUFS3—breast cancer	6.16e-06	9.46e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PTEN—breast cancer	6.12e-06	9.4e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ALDH7A1—breast cancer	6.07e-06	9.33e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ALDH1A1—breast cancer	6.07e-06	9.33e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—HSP90AA1—breast cancer	6.06e-06	9.31e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—COMT—breast cancer	6.06e-06	9.31e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—GSTP1—breast cancer	6.03e-06	9.26e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—HMOX1—breast cancer	5.95e-06	9.13e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ITPR1—breast cancer	5.93e-06	9.11e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—NCOA1—breast cancer	5.9e-06	9.06e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—CXCL8—breast cancer	5.88e-06	9.03e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ADSL—breast cancer	5.82e-06	8.94e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PHGDH—breast cancer	5.82e-06	8.94e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—UMPS—breast cancer	5.82e-06	8.94e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—NME1—breast cancer	5.82e-06	8.94e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—FHL2—breast cancer	5.82e-06	8.94e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—STK11—breast cancer	5.81e-06	8.93e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CYP19A1—breast cancer	5.81e-06	8.93e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CHST9—breast cancer	5.79e-06	8.9e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—LDHB—breast cancer	5.71e-06	8.77e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—BRIP1—breast cancer	5.71e-06	8.77e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—HPSE—breast cancer	5.71e-06	8.77e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ABCB1—breast cancer	5.71e-06	8.77e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—TYMS—breast cancer	5.6e-06	8.61e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PLA2G4A—breast cancer	5.54e-06	8.51e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—NCOR1—breast cancer	5.54e-06	8.51e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—GSTM1—breast cancer	5.54e-06	8.51e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—COX11—breast cancer	5.49e-06	8.44e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PTEN—breast cancer	5.46e-06	8.38e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—CTNNB1—breast cancer	5.42e-06	8.33e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GSTA3—breast cancer	5.41e-06	8.31e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ABCC1—breast cancer	5.41e-06	8.31e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—HMMR—breast cancer	5.41e-06	8.31e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—COMT—breast cancer	5.4e-06	8.3e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—GSTP1—breast cancer	5.38e-06	8.26e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—GPX1—breast cancer	5.31e-06	8.15e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—HMOX1—breast cancer	5.3e-06	8.15e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ITPR1—breast cancer	5.29e-06	8.13e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CYP1A1—breast cancer	5.25e-06	8.07e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—CXCL8—breast cancer	5.24e-06	8.06e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PPARGC1B—breast cancer	5.24e-06	8.05e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ERCC2—breast cancer	5.21e-06	8e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ABCB1—breast cancer	5.09e-06	7.82e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CDA—breast cancer	5.02e-06	7.71e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—SHMT1—breast cancer	5.02e-06	7.71e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—TYMS—breast cancer	5e-06	7.68e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CA9—breast cancer	4.95e-06	7.6e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GSTA4—breast cancer	4.95e-06	7.6e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—NCOR1—breast cancer	4.94e-06	7.59e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—GSTM1—breast cancer	4.94e-06	7.59e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PLA2G4A—breast cancer	4.94e-06	7.59e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—MTHFR—breast cancer	4.9e-06	7.52e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—CTNNB1—breast cancer	4.84e-06	7.43e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—SLC2A5—breast cancer	4.83e-06	7.43e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—SLCO1B1—breast cancer	4.83e-06	7.43e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GPX2—breast cancer	4.82e-06	7.41e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GSTA2—breast cancer	4.82e-06	7.41e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—SULT1A1—breast cancer	4.76e-06	7.32e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GPX4—breast cancer	4.76e-06	7.32e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—GPX1—breast cancer	4.73e-06	7.27e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CYP1A1—breast cancer	4.69e-06	7.2e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—APRT—breast cancer	4.67e-06	7.17e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GSTA1—breast cancer	4.65e-06	7.15e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—IDH1—breast cancer	4.65e-06	7.15e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ERCC2—breast cancer	4.65e-06	7.14e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—NAT2—breast cancer	4.6e-06	7.07e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CAV1—breast cancer	4.52e-06	6.94e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ESRRA—breast cancer	4.39e-06	6.74e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ANGPTL4—breast cancer	4.39e-06	6.74e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—MTHFR—breast cancer	4.37e-06	6.71e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	4.31e-06	6.63e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—HADHB—breast cancer	4.16e-06	6.39e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GPI—breast cancer	4.16e-06	6.39e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PIK3CG—breast cancer	4.11e-06	6.32e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—DPYD—breast cancer	4.03e-06	6.2e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—MED12—breast cancer	4.03e-06	6.2e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CAV1—breast cancer	4.03e-06	6.19e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ALDOA—breast cancer	3.97e-06	6.1e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ALDH7A1—breast cancer	3.97e-06	6.1e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ALDH1A1—breast cancer	3.97e-06	6.1e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—NCOA3—breast cancer	3.86e-06	5.92e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	3.85e-06	5.91e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—SLC2A2—breast cancer	3.83e-06	5.88e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ADSL—breast cancer	3.81e-06	5.85e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PHGDH—breast cancer	3.81e-06	5.85e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—UMPS—breast cancer	3.81e-06	5.85e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—NME1—breast cancer	3.81e-06	5.85e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—FHL2—breast cancer	3.81e-06	5.85e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CPT1A—breast cancer	3.75e-06	5.76e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—MTR—breast cancer	3.75e-06	5.76e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ABCG2—breast cancer	3.75e-06	5.76e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—HPSE—breast cancer	3.73e-06	5.73e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—BRIP1—breast cancer	3.73e-06	5.73e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—LDHB—breast cancer	3.73e-06	5.73e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—HPGDS—breast cancer	3.68e-06	5.65e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PIK3CG—breast cancer	3.67e-06	5.64e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—HBA1—breast cancer	3.66e-06	5.62e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PIK3CD—breast cancer	3.62e-06	5.56e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ALB—breast cancer	3.57e-06	5.48e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ACHE—breast cancer	3.57e-06	5.48e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GSTT1—breast cancer	3.57e-06	5.48e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—HMMR—breast cancer	3.54e-06	5.44e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GSTA3—breast cancer	3.54e-06	5.44e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ABCC1—breast cancer	3.54e-06	5.44e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PPARGC1B—breast cancer	3.43e-06	5.26e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—NOS3—breast cancer	3.41e-06	5.25e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CYP17A1—breast cancer	3.38e-06	5.19e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ENO1—breast cancer	3.34e-06	5.14e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PTGS1—breast cancer	3.34e-06	5.14e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GSTA4—breast cancer	3.24e-06	4.97e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CA9—breast cancer	3.24e-06	4.97e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PIK3CD—breast cancer	3.23e-06	4.96e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—NCOA2—breast cancer	3.22e-06	4.94e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ALB—breast cancer	3.18e-06	4.89e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GPX2—breast cancer	3.15e-06	4.84e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GSTA2—breast cancer	3.15e-06	4.84e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PIK3CB—breast cancer	3.15e-06	4.84e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PTGS2—breast cancer	3.12e-06	4.8e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—FASN—breast cancer	3.12e-06	4.8e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—SULT1A1—breast cancer	3.11e-06	4.79e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GPX4—breast cancer	3.11e-06	4.79e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—BCHE—breast cancer	3.11e-06	4.77e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—SLC5A5—breast cancer	3.07e-06	4.72e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—NOS3—breast cancer	3.05e-06	4.68e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—IDH1—breast cancer	3.04e-06	4.67e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GSTA1—breast cancer	3.04e-06	4.67e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—NAT2—breast cancer	3.01e-06	4.62e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—SLC2A1—breast cancer	2.96e-06	4.56e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—NQO1—breast cancer	2.96e-06	4.56e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CYP3A4—breast cancer	2.89e-06	4.44e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CYP1B1—breast cancer	2.84e-06	4.37e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PIK3CB—breast cancer	2.81e-06	4.32e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—HSP90AA1—breast cancer	2.79e-06	4.28e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PTGS2—breast cancer	2.79e-06	4.28e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PTEN—breast cancer	2.72e-06	4.18e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—NCOA1—breast cancer	2.71e-06	4.17e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—STK11—breast cancer	2.67e-06	4.11e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CYP19A1—breast cancer	2.67e-06	4.11e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—MED12—breast cancer	2.64e-06	4.05e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—DPYD—breast cancer	2.64e-06	4.05e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ALDOA—breast cancer	2.6e-06	3.99e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—NCOA3—breast cancer	2.52e-06	3.87e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—SLC2A2—breast cancer	2.5e-06	3.85e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—COMT—breast cancer	2.48e-06	3.82e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GSTP1—breast cancer	2.47e-06	3.8e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CPT1A—breast cancer	2.45e-06	3.77e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—MTR—breast cancer	2.45e-06	3.77e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ABCG2—breast cancer	2.45e-06	3.77e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—HMOX1—breast cancer	2.44e-06	3.75e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ITPR1—breast cancer	2.43e-06	3.74e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PTEN—breast cancer	2.43e-06	3.73e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—HPGDS—breast cancer	2.4e-06	3.69e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—HBA1—breast cancer	2.39e-06	3.67e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ABCB1—breast cancer	2.34e-06	3.6e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ACHE—breast cancer	2.33e-06	3.58e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GSTT1—breast cancer	2.33e-06	3.58e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—TYMS—breast cancer	2.3e-06	3.53e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GSTM1—breast cancer	2.27e-06	3.49e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PLA2G4A—breast cancer	2.27e-06	3.49e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—NCOR1—breast cancer	2.27e-06	3.49e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CYP17A1—breast cancer	2.21e-06	3.39e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PTGS1—breast cancer	2.19e-06	3.36e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ENO1—breast cancer	2.19e-06	3.36e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GPX1—breast cancer	2.18e-06	3.34e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CYP1A1—breast cancer	2.15e-06	3.31e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CYP2D6—breast cancer	2.14e-06	3.29e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ERCC2—breast cancer	2.14e-06	3.28e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—NCOA2—breast cancer	2.1e-06	3.23e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—FASN—breast cancer	2.04e-06	3.13e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—BCHE—breast cancer	2.03e-06	3.12e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—MTHFR—breast cancer	2.01e-06	3.09e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—SLC5A5—breast cancer	2.01e-06	3.08e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—SLC2A1—breast cancer	1.94e-06	2.98e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—NQO1—breast cancer	1.94e-06	2.98e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PIK3CA—breast cancer	1.92e-06	2.95e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CYP1B1—breast cancer	1.86e-06	2.86e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CAV1—breast cancer	1.85e-06	2.85e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—HSP90AA1—breast cancer	1.82e-06	2.8e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—NCOA1—breast cancer	1.77e-06	2.72e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—STK11—breast cancer	1.75e-06	2.68e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CYP19A1—breast cancer	1.75e-06	2.68e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PIK3CA—breast cancer	1.71e-06	2.63e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PIK3CG—breast cancer	1.69e-06	2.59e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—COMT—breast cancer	1.62e-06	2.5e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GSTP1—breast cancer	1.62e-06	2.48e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—HMOX1—breast cancer	1.59e-06	2.45e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ITPR1—breast cancer	1.59e-06	2.44e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—AKT1—breast cancer	1.57e-06	2.41e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ABCB1—breast cancer	1.53e-06	2.35e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—TYMS—breast cancer	1.5e-06	2.31e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.49e-06	2.28e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—NCOR1—breast cancer	1.49e-06	2.28e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GSTM1—breast cancer	1.49e-06	2.28e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PIK3CD—breast cancer	1.48e-06	2.28e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ALB—breast cancer	1.46e-06	2.25e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GPX1—breast cancer	1.42e-06	2.19e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CYP1A1—breast cancer	1.41e-06	2.16e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—NOS3—breast cancer	1.4e-06	2.15e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—AKT1—breast cancer	1.4e-06	2.15e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ERCC2—breast cancer	1.4e-06	2.15e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—MTHFR—breast cancer	1.31e-06	2.02e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PIK3CB—breast cancer	1.29e-06	1.99e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PTGS2—breast cancer	1.28e-06	1.97e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CAV1—breast cancer	1.21e-06	1.86e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PTEN—breast cancer	1.12e-06	1.72e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PIK3CG—breast cancer	1.1e-06	1.69e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PIK3CD—breast cancer	9.7e-07	1.49e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ALB—breast cancer	9.57e-07	1.47e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—NOS3—breast cancer	9.16e-07	1.41e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PIK3CB—breast cancer	8.45e-07	1.3e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PTGS2—breast cancer	8.38e-07	1.29e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PIK3CA—breast cancer	7.88e-07	1.21e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PTEN—breast cancer	7.3e-07	1.12e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—AKT1—breast cancer	6.44e-07	9.89e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PIK3CA—breast cancer	5.15e-07	7.92e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—AKT1—breast cancer	4.21e-07	6.47e-06	CbGpPWpGaD
